Gene · 29968
Papers1,996
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,996
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Scaling Up Peritoneal Dialysis in India: A Sustainability Perspective Using the Program Sustainability Assessment Tool. | Kidney Int Rep | 2025 | 41278319 | PubTator, text mining | PubMed |
| Deactivation of CK1α enhances the anti-cancer effects of salinomycin in colorectal cancer HCT116 cells. | Biochem Biophys Rep | 2025 | 41234632 | PubTator, text mining | PubMed |
| Serine metabolism reprogramming in cancer: a multi-tiered regulatory framework. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 41220284 | PubTator, text mining | PubMed |
| miR-424 Targets AKT3 and PSAT1 and Has a Tumor-Suppressive Role in Human Colorectal Cancer [Retraction]. | Cancer Manag Res | 2025 | 41185640 | PubTator, text mining | PubMed |
| PSAT1 knockdown mediated VDAC1 oligomerization promotes ferroptosis and suppresses cell proliferation in esophageal squamous cell carcinoma. | Int J Biol Macromol | 2025 | 41061782 | PubTator, text mining | PubMed |
| Bronchoalveolar lavage proteomics in exacerbation of bronchiectasis. | BMC Pulm Med | 2025 | 41034841 | PubTator, text mining | PubMed |
| Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications. | J Pers Med | 2025 | 41003134 | PubTator, text mining | PubMed |
| Lysosome-related molecular subtypes reveal prognostic signatures and immunotherapeutic implications in ovarian cancer. | Sci Rep | 2025 | 40998924 | PubTator, text mining | PubMed |
| An integrated multi-omic natural history study of human development, sexual dimorphism, and the effects of trisomy 21. | Nat Commun | 2025 | 40993118 | PubTator, text mining | PubMed |
| Metabolic Reprogramming of Cancer Cells and Therapeutics Targeting Cancer Metabolism. | Cancer Med | 2025 | 40956032 | PubTator, text mining | PubMed |
| Construction of prognostic risk prediction model of endometrial carcinoma based on bioinformatics analysis. | Medicine (Baltimore) | 2025 | 40898536 | PubTator, text mining | PubMed |
| DKC1-mediated pseudouridylation of rRNA targets hnRNP A1 to sustain IRES-dependent translation and ATF4-driven metabolic adaptation. | Sci Adv | 2025 | 40880467 | PubTator, text mining | PubMed |
| Metabolic dysregulation in pulmonary fibrosis: insights into amino acid contributions and therapeutic potential. | Cell Death Discov | 2025 | 40858556 | PubTator, text mining | PubMed |
| A novel prognostic signature integrating disulfidptosis- and ferroptosis-related genes in acute myeloid leukemia. | Clin Exp Med | 2025 | 40853395 | PubTator, text mining | PubMed |
| Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trial. | Nat Commun | 2025 | 40825784 | PubTator, text mining | PubMed |
| Empowering hypoxia to convert cold tumors into hot tumors for breast cancer immunotherapy. | Cell Death Discov | 2025 | 40813760 | PubTator, text mining | PubMed |
| Histone lactylation-boosted AURKB facilitates colorectal cancer progression by inhibiting HNRNPM-mediated PSAT1 mRNA degradation. | J Exp Clin Cancer Res | 2025 | 40784984 | PubTator, text mining | PubMed |
| Modulating the serine metabolism in human differentiated astrocytes: an integrated multi omics approach. | Front Cell Neurosci | 2025 | 40761926 | PubTator, text mining | PubMed |
| Imaging the uptake and metabolism of glutamine in prostate tumor models using CEST MRI. | Npj Imaging | 2025 | 40750673 | PubTator, text mining | PubMed |
| New insights into the dule roles CDK12 in human cancers: Mechanisms and interventions for cancer therapy. | J Pharm Anal | 2025 | 40747342 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29968/papers?page=4